Centene Corporation (NYSE:CNC) Director Robert K. Ditmore sold 4,167 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The stock was sold at an average price of $90.42, for a total transaction of $376,780.14. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Centene Corporation (NYSE CNC) traded down 0.64% during trading on Monday, reaching $93.81. 1,070,916 shares of the company were exchanged. The firm’s 50 day moving average price is $94.14 and its 200-day moving average price is $83.55. Centene Corporation has a one year low of $50.00 and a one year high of $98.71. The stock has a market capitalization of $16.18 billion, a price-to-earnings ratio of 20.59 and a beta of 0.68.

Centene Corporation (NYSE:CNC) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.35 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.11. Centene Corporation had a return on equity of 14.79% and a net margin of 1.81%. The business had revenue of $11.90 billion for the quarter, compared to analysts’ expectations of $11.75 billion. During the same period in the previous year, the business posted $1.12 EPS. The firm’s quarterly revenue was up 9.7% compared to the same quarter last year. On average, equities research analysts predict that Centene Corporation will post $4.97 earnings per share for the current year.

WARNING: “Centene Corporation (CNC) Director Sells $376,780.14 in Stock” was originally published by American Banking News and is the property of of American Banking News. If you are reading this report on another website, it was stolen and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/10/30/centene-corporation-cnc-director-sells-376780-14-in-stock.html.

A number of institutional investors have recently made changes to their positions in the stock. CFO4Life Group LLC raised its stake in Centene Corporation by 0.4% in the 2nd quarter. CFO4Life Group LLC now owns 6,598 shares of the company’s stock valued at $527,000 after acquiring an additional 25 shares during the period. MML Investors Services LLC increased its position in shares of Centene Corporation by 1.0% during the second quarter. MML Investors Services LLC now owns 3,587 shares of the company’s stock valued at $287,000 after buying an additional 34 shares during the period. Keybank National Association OH increased its position in shares of Centene Corporation by 1.1% during the second quarter. Keybank National Association OH now owns 3,180 shares of the company’s stock valued at $254,000 after buying an additional 36 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of Centene Corporation by 0.3% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,799 shares of the company’s stock valued at $1,022,000 after buying an additional 38 shares during the period. Finally, Somerset Trust Co increased its position in shares of Centene Corporation by 0.5% during the second quarter. Somerset Trust Co now owns 8,102 shares of the company’s stock valued at $647,000 after buying an additional 40 shares during the period. Institutional investors and hedge funds own 92.86% of the company’s stock.

A number of brokerages recently issued reports on CNC. Oppenheimer Holdings Inc. restated a “buy” rating and set a $105.00 price objective on shares of Centene Corporation in a report on Tuesday, October 24th. Piper Jaffray Companies restated a “buy” rating and set a $105.00 price objective on shares of Centene Corporation in a report on Thursday, July 27th. Cantor Fitzgerald restated a “buy” rating and set a $107.00 price objective on shares of Centene Corporation in a report on Tuesday, October 24th. Jefferies Group LLC restated a “buy” rating and set a $98.00 price objective on shares of Centene Corporation in a report on Thursday, July 27th. Finally, ValuEngine upgraded shares of Centene Corporation from a “hold” rating to a “buy” rating in a report on Thursday, July 27th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and seventeen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $96.42.

About Centene Corporation

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Insider Buying and Selling by Quarter for Centene Corporation (NYSE:CNC)

Receive News & Ratings for Centene Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene Corporation and related companies with MarketBeat.com's FREE daily email newsletter.